Promotion of autophagy as a mechanism for radiation sensitization of breast tumor cells

Radiotherapy and Oncology

Volumn 92, Issue 3, 2009, Pages 323-328

  Gewirtz, David A ^a   Hilliker, Molly L ^a   Wilson, Eden N ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Autophagy; Breast cancer; Radiation; Vitamin D

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; SEOCALCITOL; VITAMIN D;

APOPTOSIS; AUTOPHAGY; BREAST TUMOR; CANCER RECURRENCE; CELL PROTECTION; CELL STRAIN MCF 7; CHEMOPROPHYLAXIS; HUMAN; PRIORITY JOURNAL; RADIOSENSITIZATION; REVIEW; TUMOR CELL;

APOPTOSIS; AUTOPHAGY; BREAST NEOPLASMS; CELL LINE, TUMOR; CHOLECALCIFEROL; DNA DAMAGE; DNA REPAIR; FEMALE; HUMANS; RADIATION TOLERANCE; RADIATION, IONIZING; SENSITIVITY AND SPECIFICITY;

EID: 69949157795     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.05.022     Document Type: Review

References (92)

1. Jin Z., and El-Deiry W.S. Overview of cell death signaling pathways. Cancer Biol Ther 4 (2005) 139-163
2. Schmitt C.A., Fridman J.S., Yang M., Lee S., Baranov E., Hoffman R.M., et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109 (2002) 335-346
3. Chu K., Teele N., Dewey M.W., Albright N., and Dewey W.C. Computerized video time lapse study of cell cycle delay and arrest, mitotic catastrophe, apoptosis and clonogenic survival in irradiated 14-3-3sigma and CDKN1A (p21) knockout cell lines. Radiat Res 162 (2004) 270-286
4. Danson S., Dean E., Dive C., and Ranson M. IAPs as a target for anticancer therapy. Curr Cancer Drug Targets 7 (2007) 785-794
5. Hsu P.C., Hung H.C., Liao Y.F., Liu C.C., Tsay G.J., and Liu G.Y. Ornithine decarboxylase attenuates leukemic chemotherapy drugs-induced cell apoptosis and arrest in human promyelocytic HL-60 cells. Leuk Res 32 (2008) 1530-1540
6. Roninson I.B., Broude E.V., and Chang B.D. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 4 (2001) 303-313
7. Schmitt C.A. Cellular senescence and cancer treatment. Biochim Biophys Acta 1775 (2007) 5-20
8. Katakura Y. Molecular basis for the cellular senescence program and its application to anticancer therapy. Biosci Biotechnol Biochem 70 (2006) 1076-1081
9. Gewirtz D.A., Holt S.E., and Elmore L.W. Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol 76 (2008) 947-957
10. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92 (1995) 9363-9367
11. Xue W., Zender L., Miething C., Dickins R.A., Hernando E., Krizhanovsky V., et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445 (2007) 656-660
12. Ventura A., Kirsch D.G., McLaughlin M.E., Tuveson D.A., Grimm J., Lintault L., et al. Restoration of p53 function leads to tumour regression in vivo. Nature 445 (2007) 661-665
13. Roberson R.S., Kussick S.J., Vallieres E., Chen S.Y., and Wu D.Y. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers. Cancer Res 65 (2005) 2795-2803
14. te Poele R.H., Okorokov A.L., Jardine L., Cummings J., and Joel S.P. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 62 (2002) 1876-1883
15. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ 8 (2001) 569-581
16. Klionsky D.J., and Emr S.D. Autophagy as a regulated pathway of cellular degradation. Science 290 (2000) 1717-1721
17. Eisenberg-Lerner A., and Kimchi A. The paradox of autophagy and its implication in cancer etiology and therapy. Apoptosis 14 (2009) 376-391 [Review]
18. Tsuchihara K., Fujii S., and Esumi H. Autophagy and cancer: dynamism of the metabolism of tumor cells and tissues. Cancer Lett 278 (2009) 130-138
19. Lock R.B., and Stribinskiene L. Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res 56 (1996) 4006-4012
20. Bunz F., Hwang P.M., Torrance C., Waldman T., Zhang Y., Dillehay L., et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest 104 (1999) 263-269
21. Rebbaa A., Zheng X., Chou P.M., and Mirkin B.L. Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene 22 (2003) 2805-2811
22. Eom Y.W., Kim M.A., Park S.S., Goo M.J., Kwon H.J., Sohn S., et al. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene 24 (2005) 4765-4777
23. Park S.S., Eom Y.W., and Choi K.S. Cdc2 and Cdk2 play critical roles in low dose doxorubicin-induced cell death through mitotic catastrophe but not in high dose doxorubicin-induced apoptosis. Biochem Biophys Res Commun 334 (2005) 1014-1021
24. Demasters G., Di X., Newsham I., Shiu R., and Gewirtz D.A. Potentiation of radiation sensitivity in breast tumor cells by the vitamin D3 analogue, EB 1089, through promotion of autophagy and interference with proliferative recovery. Mol Cancer Ther 5 (2006) 2786-2797
25. Young A.R., Narita M., Ferreira M., Kirschner K., Sadaie M., Darot J.F., et al. Autophagy mediates the mitotic senescence transition. Genes Dev 23 (2009) 798-803
26. Yang C., Kaushal V., Shah S.V., and Kaushal G.P. Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cells. Am J Physiol Renal Physiol 294 (2008) F777-F787
27. 2-terminal kinase/extracellular signal-regulated kinase activation in WI38 lung epithelial fibroblast cells. J Pharmacol Exp Ther 329 (2009) 112-122
28. Choi S.E., Lee S.M., Lee Y.J., Li L.J., Lee S.J., Lee J.H., et al. Protective role of autophagy in palmitate-induced INS-1 beta-cell death. Endocrinology 50 (2009) 126-134
29. Muñoz-Gámez J.A., Rodríguez-Vargas J.M., Quiles-Pérez R., Aguilar-Quesada R., Martín-Oliva D., de Murcia G., et al. PARP-1 is involved in autophagy induced by DNA damage. Autophagy 5 (2009) 61-74
30. Qadir M.A., Kwok B., Dragowska W.H., To K.H., Le D., Bally M.B., et al. Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization. Breast Cancer Res Treat 112 (2008) 389-403
31. Harhaji-Trajkovic L., Vilimanovich U., Kravic-Stevovic T., Bumbasirevic V., and Trajkovic V. AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumor cells. J Cell Mol Med (2009)
32. Han J., Hou W., Goldstein L.A., Lu C., Stolz D.B., Yin X.M., et al. Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells. J Biol Chem 283 (2008) 19665-19677
33. Sy L.K., Yan S.C., Lok C.N., Man R.Y., and Che C.M. Timosaponin A-III induces autophagy preceding mitochondria-mediated apoptosis in HeLa cancer cells. Cancer Res 68 (2008) 10229-10237
34. Li J., Hou N., Faried A., Tsutsumi S., Takeuchi T., and Kuwano H. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol 16 (2009) 761-771
35. Shingu T., Fujiwara K., Bögler O., Akiyama Y., Moritake K., Shinojima N., et al. Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells. Int J Cancer 124 (2009) 1060-1071
36. Amaravadi R.K., Yu D., Lum J.J., Bui T., Christophorou M.A., Evan G.I., et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117 (2007) 326-336
37. Abedin M.J., Wang D., McDonnell M.A., Lehmann U., and Kelekar A. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ 14 (2007) 500-510
38. Janicke R.U., Spregart M.L., and Wati M.R. And Porter AG: caspase 3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273 (1998) 9357-9360
39. Akar U., Chaves-Reyez A., Barria M., Tari A., Sanguino A., Kondo Y., et al. Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy 4 (2008) 669-679
40. Lambert L.A., Qiao N., Hunt K.K., Lambert D.H., Mills G.B., Meijer L., et al. Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model. Cancer Res 68 (2008) 7966-7974
41. Di X., Shiu R.P., Newsham I.F., and Gewirtz D.A. Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to adriamycin. Biochem Pharmacol 77 (2009) 1139-1150
42. Oh S.H., Kim Y.S., Lim S.C., Hou Y.F., Chang I.Y., and You H.J. Dihydrocapsaicin (DHC), a saturated structural analog of capsaicin, induces autophagy in human cancer cells in a catalase-regulated manner. Autophagy 4 (2008) 1009-1019
43. Lee S.B., Tong S.Y., Kim J.J., Um S.J., and Park J.S. Caspase-independent autophagic cytotoxicity in etoposide-treated CaSki cervical carcinoma cells. DNA Cell Biol 26 (2007) 713-720
44. Górka M., Daniewski W.M., Gajkowska B., Lusakowska E., Godlewski M.M., and Motyl T. Autophagy is the dominant type of programmed cell death in breast cancer MCF-7 cells exposed to AGS 115 and EFDAC, new sesquiterpene analogs of paclitaxel. Anticancer Drugs 16 (2005) 777-788
45. Arthur C.R., Gupton J.T., Kellogg G.E., Yeudall W.A., Cabot M.C., Newsham I.F., et al. Autophagic cell death, polyploidy and senescence induced in breast tumor cells by the substituted pyrrole JG-03-14, a novel microtubule poison. Biochem Pharmacol 74 (2007) 981-989
46. Bommareddy A., Hahm E.R., Xiao D., Powolny A.A., Fisher A.L., Jiang Y., et al. Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells. Cancer Res 69 (2009) 3704-3712
47. Paglin S., Hollister T., Delohery T., Hackett N., McMahill M., Sphicas E., et al. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 61 (2002) 439-444
48. Paglin S., Lee N.Y., Nakar C., Fitzgerald M., Plotkin J., Deuel B., et al. Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells. Cancer Res 65 (2005) 11061-11070
49. Tsuboi Y., Kurimoto M., Nagai S., Hayakawa Y., Kamiyama H., Hayashi N., Kitajima I., and Endo S. Induction of autophagic cell death and radiosensitization by the pharmacological inhibition of nuclear factor-kappa B activation in human glioma cell lines. J Neurosurg 110 (2009) 594-604
50. Rieber M., and Rieber M.S. Sensitization to radiation-induced DNA damage accelerates loss of bcl-2 and increases apoptosis and autophagy. Cancer Biol Ther 7 (2008) 1561-1566
51. Pan J., Chen B., Su C.H., Zhao R., Xu Z.X., Sun L., et al. Autophagy induced by farnesyltransferase inhibitors in cancer cells. Cancer Biol Ther 7 (2008) 1679-1684
52. Smith E.L., and Schuchman E.H. Acid sphingomyelinase overexpression enhances the antineoplastic effects of irradiation in vitro and in vivo. Mol Ther 16 (2008) 1565-1571
53. Cao C., Subhawong T., Albert J.M., Kim K.W., Geng L., Sekhar K.R., et al. Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. Cancer Res 66 (2006) 10040-10047
54. Albert J.M., Kim K.W., Cao C., and Lu B. Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer. Mol Cancer Ther 5 (2006) 1183-1189
55. Kim K.W., Hwang M., Moretti L., Jaboin J.J., Cha Y.I., and Lu B. Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy 4 (2008) 659-668
56. Fujiwara K., Iwado E., Mills G.B., Sawaya R., Kondo S., and Kondo Y. Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagy. Int J Oncol 31 (2007) 753-760
57. Kim K.W., Mutter R.W., Cao C., Albert J.M., Freeman M., Hallahan D.E., et al. Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling. J Biol Chem 281 (2006) 36883-36890
58. Daido S., Yamamoto A., Fujiwara K., Sawaya R., Kondo S., and Kondo Y. Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy. Cancer Res 65 (2005) 4368-4375
59. Peng P.L., Kuo W.H., Tseng H.C., and Chou F.P. Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death. Int J Radiat Oncol Biol Phys 70 (2008) 529-542
60. Kim K.W., Moretti L., and Lu B. M867, a novel selective inhibitor of caspase-3 enhances cell death and extends tumor growth delay in irradiated lung cancer models. PLoS ONE 3 (2008) e2275
61. Benzina S., Altmeyer A., Malek F., Dufour P., Denis J.M., Gueulette J., et al. High-LET radiation combined with oxaliplatin induce autophagy in U-87 glioblastoma cells. Cancer Lett 264 (2008) 63-70
62. Ito H., Daido S., Kanzawa T., Kondo S., and Kondo Y. Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells. Int J Oncol 26 (2005) 1401-1410
63. Apel A., Herr I., Schwarz H., Rodemann H.P., and Mayer A. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res 68 (2008) 1485-1494
64. Lomonaco S.L., Finniss S., Xiang C., Decarvalho A., Umansky F., Kalkanis S.N., et al. The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. Int J Cancer (2009) [Epub ahead of print]
65. Zois C.E., and Koukourakis M.I. Radiation-induced autophagy in normal and cancer cells: towards novel cytoprotection and radio-sensitization policies?. Autophagy 5 (2009) 442-450
66. Lehmann B.D., McCubrey J.A., and Terrian D.M. Radiosensitization of prostate cancer by priming the wild-type p53-dependant cellular senescence pathway. Cancer Bio Ther 6 (2007) 1165-1170
67. Kil W.J., Cerna D., Burgan W.E., Beam K., Carter D., Steeg P.S., et al. In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide. Clin Cancer Res 14 (2008) 931-938
68. Sundaram S., and Gewirtz D.A. The vitamin D3 analog EB 1089 enhances the response of human breast tumor cells to radiation. Radiat Res 152 (1999) 479-486
69. Sundaram S., Chaudhry M., Reardon D., and Gewirtz D.A. EB 1089 enhances the antiproliferative and apoptotic effects of adriamycin in MCF-7 breast tumor cells. Breast Cancer Res Treat 63 (2000) 1-10
70. Elmore L.W., Rehder C.W., Di X., McChesney P.A., Jackson-Cook C.K., Gewirtz D.A., et al. Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction. J Biol Chem 277 (2002) 35509-35515
71. Sundaram S., Sea A., Feldman S., Strawbridge R., Hoopes P.J., Demidenko E., et al. The combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice. Clin Cancer Res 9 (2003) 2350-2356
72. DeMasters G., Gupta M., Jones K.R., Cabot M., Wang H., Gennings C., et al. Potentiation of cell killing by fractionated radiation and suppression of proliferative recovery in MCF-7 breast tumor cells by the vitamin D3 analog, EB 1089. J Steroid Biochem Mol Biol 92 (2004) 364-375
73. Elmore L.W., Di X., Dumur C., Holt S.E., and Gewirtz D.A. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response. Clin Cancer Res 11 (2005) 2637-2643
74. Jones K.R., Elmore L., Jackson Cooke C., DeMasters G., Holt S.E., Povirk L.F., et al. P53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells. Int J Radiat Biol 81 (2005) 445-458
75. 3 analog, EB 1089, through promotion of autophagy and interference with proliferative recovery. Mol Cancer Ther 5 (2006) 2786-2797
76. Pietras R.J., Pegram M.D., and Slamon D.J. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs. Oncogene 17 (1998) 2235-2249
77. Schueneman A.J., Himmelfarb E., Geng L., Tan J., Donnelly E., Mendel D., et al. SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models. Cancer Res 63 (2003) 4009-4016
78. Moretti L., Kim K.W., Jung D.K., Willey C.D., and Lu B. Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor. Mol Cancer Ther (2009)
79. Hansen C.M., Hamberg K.J., and Binderup L. Seocalcitol (EB1089): a vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical, and clinical evaluation. Curr Pharm Des 6 (2000) 803-828
80. Hansen C.M., Binderup L., Hamberg K.J., and Carlberg C. Vitamin D and cancer: effects of 1, 25(OH)2D3 and its analogs on growth control and tumorigenesis. Front Biosci 6 (2001) 820-848
81. Cho Y.L., Christensen C., Saunders D.E., et al. Combined effects of 1,25-dihydroxyvitamin D3 and platinum drugs on the growth of MCF-7 cells. Cancer Res 51 (1991) 2848-2853
82. Saunders D.E., Christensen C., Wappler N.L., Cho Y.L., Lawrence W.D., Malone J.M., et al. Additive inhibition of RL95-2 endometrial carcinoma cell growth by carboplatin and 1,25 dihydroxyvitamin D3. Gynecol Oncol 51 (1993) 155-159
83. Light B.W., Yu W.D., McElwain M.C., et al. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res 57 (1997) 3759-3764
84. Moffatt K.A., Johannes W.U., and Miller G.J. 1 alpha,25 dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit growth of prostate cancer cell lines. Clin Cancer Res 5 (1999) 695-703
85. Ravid A., Rocker D., Machlenkin A., et al. 1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage. Cancer Res 59 (1999) 862-867
86. Rashid S.F., Moore J.S., Walker E., Driver P.M., Engel J., Edwards C.E., et al. Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 dihydroxyvitamin D3 and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A. Oncogene 20 (2001) 1860-1872
87. Hershberger P.A., Yu W.D., Modzelewski R.A., et al. Calcitriol (1,25-dihydroxycholecalciferol): enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis. Clin Cancer Res 7 (2001) 1043-1051
88. Bernardi R.J., Trump D.L., Yu W.D., McGuire T.F., Hershberger P.A., and Johnson C.S. Combination of 1 alpha,25 dihydroxyvitamin D3 with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross talk and erk/akt signaling. Clin Cancer Res 7 (2001) 4164-4173
89. Dunlap N., Schwartz G.G., Eads D., Cramer S.D., Sherk A.B., John V., et al. 1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells. Br J Cancer 89 (2003) 746-753
90. Xu Y., Fang F., St. Clair D.K., Josson S., Sompol P., Spasojevic I., et al. Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1alpha,25-dihydroxyvitamin D(3) in prostate cancer cells. Mol Cancer Ther 6 (2007) 2048-2056
91. Mineva N.D., Wang X., Yang S., Ying H., Xiao Z.X., Holick M.F., et al. Inhibition of RelB by 1,25-dihydroxyvitamin D(3) promotes sensitivity of breast cancer cells to radiation. J Cell Physiol (2009) [Epub ahead of print]
92. Lu Z., Luo R.Z., Lu Y., Zhang X., Yu Q., Khare S., et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest 118 (2008) 3917-3929